Retailers

Pets at Home launches £100K feline pancytopenia research fund

The fund will provide financial support to academics, institutions and researchers who are seeking to better understand the condition, identify causes, and improve treatment options.

Pets at Home Group has launched a £100k feline pancytopenia research fund.

Pancytopenia is a rare bone marrow condition where the number of blood cells rapidly decreases, causing serious illness.

According to the retailer, the launch of this fund follows the “distressing” spike in cases of pancytopenia in cats last year. Pets at Home said it was “disappointed” that a definitive cause was unable to be found following an extensive investigation by the Food Standards Agency (FSA), and last year committed to funding further studies in order to improve knowledge within this area.

The fund will provide financial support to academics, institutions and researchers who are seeking to better understand the condition, identify causes, and improve treatment options. Through this initiative, Pets at Home hopes to find long-term solutions to feline pancytopenia and help prevent the devastating loss of so many pets.

Huw Stacey, director of clinical services, said: “For us, pets come first and always will. We supported the FSA’s investigation throughout but flagged at the time that we believed further research was required into this disease and its causes.

“As a result, we are launching this £100k fund to accelerate research into feline pancytopenia and improve understanding within this area.”

He added: “We recognise the pain and upset that this illness has caused, and our hearts go out to all the families whose cats suffered during the pancytopenia outbreak last year.”

Back to top button